The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2020 | Risk factors for progression in MPNs
Andrew Kuykendall, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses factors that predict progression in myeloproliferative neoplasms, including clinical and genetic characteristics that can result in acute leukemia development. Dr Kuykendall also highlights the role of inflammatory cytokines that have been implicated in the development of MPNs. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
